US FDA’s Califf Notes ‘Price To Pay’ For Missed Inspections During Senate COVID Funding Hearing
As Senate HELP Committee meetings questioned Commissioner Califf about backlog of inspections and FDA staff continuing to work remotely, Sen. Burr promises to be a roadblock to emergency COVID-19 funding.
You may also be interested in...
Moderna, Pfizer Nab Unanimous Votes For Pediatric COVID Vaccines But Advisors Hint At Moderna Dosing Advantage
US FDA advisory committee members raised some concerns regarding Pfizer’s three-dose schedule for children under five, suggesting Moderna’s two-dose primary series may be preferred.
US FDA May Rethink White Oak Campus As Agency Plots ‘New Normal’ For Work
A pilot project on the future of work at the FDA could lead to reduced office space requirements and improve recruitment and retention, officials say.
Surprise US FDA Facility Inspections Resume In India
Unannounced facility visits also were to start again in China, but FDA Commissioner Robert Califf said they have been delayed by the COVID-19 outbreak in the country.